Long ‐term safety and effectiveness of brexpiprazole in Japanese patients with schizophrenia: A 52‐week, open‐label study

Psychiatry and Clinical Neurosciences, EarlyView.

Source: Psychiatry and Clinical Neurosciences - April 27, 2018 Category: Neuroscience Authors: Jun Ishigooka MD, PhD , Shuichi Iwashita MSc , Yoshihiro Tadori PhD Source Type: research